Skip to main content
. 2022 Jun 23;35:103097. doi: 10.1016/j.nicl.2022.103097

Table 1.

Summary of patient demographics, lesion characteristics, histopathology and intraoperative MRI availabilities.

ID Age (years) Sex (M/F) Pathology Lesion site iMRI1 iMRI2 Lesion size (ml)
1 13.42 F Cerebral gliosis (secondary to previous tumor resection) F Y 3.9
2 13.42 M FCD T Y Y 16.5
3 3.75 M TSC (cortical tuber) F, T Y Y 9.5
4 15.83 M DNET F Y Y 13.5
5 15.50 M Presumed Rasmussen encephalitis F Y 12.4
6 12.25 M Cerebral gliosis (secondary to previous tumor resection) T Y 20.7
7 4.83 M FCD F Y Y 3.9
8 10.17 F Non-specific pathology T Y Y 31.5
9 3.92 F DNET TPO Y Y 7.3
10 4.17 M TSC (cortical tuber) F Y Y 7.8
11 3.83 M FCD F Y 76.4
12 4.50 M FCD F, T, P, I Y 163.3
13 10.92 F DNET O Y Y 7.0
14 13.25 F DNET TPO Y 5.2
15 16.08 M FCD F Y Y 2.9
16 12.17 F DNET TPO Y Y 24.2
17 5.05 F Pilocytic astrocytoma Thalamus Y 31.1

Abbreviations: Dysembryoplastic neuroepithelial tumors, DNET; Focal cortical dysplasia, FCD; Tuberous Sclerosis Complex, TSC; Temporal lobe, T, Frontal lobe, F; Parietal lobe, P; Insular cortex, I; Temporo-parieto-occipital junction, TPO; Yes, Y.